GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Intco Medical Technology Co Ltd (SZSE:300677) » Definitions » Cyclically Adjusted Revenue per Share

Intco Medical Technology Co (SZSE:300677) Cyclically Adjusted Revenue per Share : ¥11.46 (As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Intco Medical Technology Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Intco Medical Technology Co's adjusted revenue per share for the three months ended in Mar. 2025 was ¥3.889. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥11.46 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2025-06-01), Intco Medical Technology Co's current stock price is ¥23.71. Intco Medical Technology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥11.46. Intco Medical Technology Co's Cyclically Adjusted PS Ratio of today is 2.07.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Intco Medical Technology Co was 2.11. The lowest was 1.88. And the median was 1.98.


Intco Medical Technology Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Intco Medical Technology Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intco Medical Technology Co Cyclically Adjusted Revenue per Share Chart

Intco Medical Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Intco Medical Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 11.46

Competitive Comparison of Intco Medical Technology Co's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, Intco Medical Technology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intco Medical Technology Co's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Intco Medical Technology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Intco Medical Technology Co's Cyclically Adjusted PS Ratio falls into.


;
;

Intco Medical Technology Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Intco Medical Technology Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.889/115.1156*115.1156
=3.889

Current CPI (Mar. 2025) = 115.1156.

Intco Medical Technology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201512 0.000 100.600 0.000
201603 0.678 102.200 0.764
201606 0.696 101.400 0.790
201609 0.788 102.400 0.886
201612 0.839 102.600 0.941
201703 1.009 103.200 1.126
201706 1.186 103.100 1.324
201709 0.930 104.100 1.028
201712 0.831 104.500 0.915
201803 0.800 105.300 0.875
201806 0.839 104.900 0.921
201809 0.941 106.600 1.016
201812 1.006 106.500 1.087
201903 0.920 107.700 0.983
201906 0.933 107.700 0.997
201909 0.931 109.800 0.976
201912 1.081 111.200 1.119
202003 1.363 112.300 1.397
202006 5.559 110.400 5.796
202009 10.891 111.700 11.224
202012 7.700 111.500 7.950
202103 10.321 112.662 10.546
202106 5.416 111.769 5.578
202109 4.774 112.215 4.897
202112 3.709 113.108 3.775
202203 3.562 114.335 3.586
202206 2.146 114.558 2.156
202209 2.244 115.339 2.240
202212 2.080 115.116 2.080
202303 2.364 115.116 2.364
202306 2.582 114.558 2.595
202309 2.677 115.339 2.672
202312 2.860 114.781 2.868
202403 3.330 115.227 3.327
202406 3.592 114.781 3.602
202409 3.921 115.785 3.898
202412 3.852 114.893 3.859
202503 3.889 115.116 3.889

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Intco Medical Technology Co  (SZSE:300677) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Intco Medical Technology Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=23.71/11.46
=2.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 12 years, the highest Cyclically Adjusted PS Ratio of Intco Medical Technology Co was 2.11. The lowest was 1.88. And the median was 1.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Intco Medical Technology Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Intco Medical Technology Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Intco Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 18, Qingtian Road, Qilu Chemical Industrial Park, Shandong Province, Linzi District, Zibo, CHN, 255414
Intco Medical Technology Co Ltd is a manufacturer of medical disposable products and durable medical equipment. The company's main businesses cover the research and development, production and sales of disposable medical gloves, wheelchairs and non-woven fabrics, hot and cold therapy, electrodes and other products.
Executives
Liu Fang Yi Director
Chen Qiong Directors, executives
Feng Jie Executives
Li Bin Directors, executives
Yu Hai Sheng Directors, executives
Li Qing Ming Securities Affairs Representative

Intco Medical Technology Co Headlines

No Headlines